EMILY SHARP: Open Payments
NPI 1427500628 · SEWICKLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,673 in 90 payments from 16 companies in 2025. Trend: 2023 $2,403 · 2024 $2,531 · 2025 $1,673
Food & beverage: $1,583Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 37 | $617 |
| GENZYME CORPORATION | 10 | $172 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| UCB, Inc. | 4 | $106 |
| PFIZER INC. | 5 | $100 |
| Lilly USA, LLC | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| Amgen Inc. | 4 | $91 |
| Arcutis Biotherapeutics, Inc. | 3 | $82 |
| ABBVIE INC. | 3 | $55 |
Products named: TREMFYA, DUPIXENT, AXERT, Bimzelx, CIBINQO, TALTZ, Sotyktu, OTEZLA.
Industry payments across PA — which companies pay providers there.
